Diagnosing type 2 diabetes and identifying high-risk individuals using the new glycated haemoglobin (HbA1c) criteria

By Leach Mick   Evans Philip H   Pereira Gray Denis J   Wright Christine   Langley Peter  

British Journal of General Practice, Vol. 63, Iss. 610, 2013-05 ,pp. : 235-235

Royal College of General Practitioners

Access to resources Recommend Favorite

Metformin pharmacokinetics in Indigenous Australian patients

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 4, 2015-04 ,pp. : 617-623

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neuroendocrine responses to hypoglycaemia decrease within the first year after diagnosis of type 1 diabetes

By Damholt M. B.   Christensen N. J.   Hilsted J.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 61, Iss. 7, 2001-11 ,pp. : 531-537

Informa Healthcare

Access to resources Recommend Favorite

Low levels of C‐peptide have clinical significance for established Type 1 diabetes

By  

DIABETIC MEDICINE, Vol. 742-3071, Iss. 10, 2015-10 ,pp. : 1346-1353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictors of achieving HbA 1c <7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study

By Valensi Paul  

Current Medical Research and Opinion, Vol. 29, Iss. 6, 2013-06 ,pp. : 601-609

Informa Healthcare

Access to resources Recommend Favorite